Oakbrook Investments’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-647	Closed	-$591K	–	634
2018 Q3	$591K	Buy	647 +197	+44%	+$180K	0.03%	410
2018 Q2	$330K	Buy	+450	New	+$330K	0.02%	436